The antiangiogenic ceiling in hepatocellular carcinoma: Does it exist and has it been reached? Journal Article
| Authors: | Abou-Alfa, G. K.; Venook, A. P. |
| Article Title: | The antiangiogenic ceiling in hepatocellular carcinoma: Does it exist and has it been reached? |
| Keywords: | overall survival; sorafenib; bevacizumab; doxorubicin; erlotinib; placebo; sunitinib; advanced cancer; drug efficacy; drug safety; hepatitis b; hepatitis c; hypertension; liver cell carcinoma; liver cirrhosis; monotherapy; nonhuman; note; capecitabine; gemcitabine; gastrointestinal stromal tumor; progression free survival; bleeding; cancer resistance; survival time; thrombosis; antiangiogenic therapy; oxaliplatin; artery thrombosis; scatter factor receptor; brivanib; pancreatic neuroendocrine tumor; cabozantinib; child pugh score; tivantinib; linifanib; varix bleeding |
| Journal Title: | Lancet Oncology |
| Volume: | 14 |
| Issue: | 7 |
| ISSN: | 1470-2045 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2013-06-01 |
| Start Page: | e283 |
| End Page: | e288 |
| Language: | English |
| DOI: | 10.1016/s1470-2045(13)70161-x |
| PROVIDER: | scopus |
| PUBMED: | 23725711 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 July 2013" - "CODEN: LOANB" - "Source: Scopus" |
